Clear-cell Metastatic Renal Cell Carcinoma

Showing 1 - 15 of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

go Back Into Records and Observe How People With Metastatic

Not yet recruiting
  • Carcinoma, Renal Cell
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Istanbul, Turkey
    Pfizer
Feb 15, 2023

Clear-cell Metastatic Renal Cell Carcinoma Trial in Guangzhou (Drug: Pembrolizumab)

Not yet recruiting
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Drug: Pembrolizumab
  • Guangzhou, Guangdong, China
  • +1 more
Oct 7, 2022

Clear-Cell Metastatic Renal Cell Carcinoma, Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult Trial in Montreal,

Active, not recruiting
  • Clear-Cell Metastatic Renal Cell Carcinoma
  • +4 more
  • Montreal, Quebec, Canada
  • +3 more
Aug 2, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

IMaging PAtients for Cancer Drug selecTion - Renal Cell

Completed
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Kidney Neoplasms
  • Molecular imaging
  • Amsterdam, Netherlands
  • +2 more
Dec 6, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Everolimus, MLN0128, MLN1117)

Completed
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Los Angeles, California
  • +35 more
Nov 18, 2021

Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Nivolumab/Ipilimumab)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab/Ipilimumab
  • Linz, Austria
  • +34 more
Aug 3, 2021

Clear-cell Metastatic Renal Cell Carcinoma Trial in Brussel (patients with sunitinib or pazopanib)

Terminated
  • Clear-cell Metastatic Renal Cell Carcinoma
  • patients with sunitinib or pazopanib
  • Brussel, Belgium
    Cliniques universitaires Saint-Luc
Mar 18, 2021

Clear-cell Metastatic Renal Cell Carcinoma Trial in United Kingdom (Axitinib)

Unknown status
  • Clear-cell Metastatic Renal Cell Carcinoma
  • London, Sutton, United Kingdom
  • +5 more
Feb 6, 2019

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of varlilumab and sunitinib)

Terminated
  • Carcinoma, Renal Cell
  • +8 more
  • Combination of varlilumab and sunitinib
  • Birmingham, Alabama
  • +8 more
Jul 24, 2018

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

Terminated
  • Carcinoma, Renal Cell
  • +13 more
  • Combination of Varlilumab and Atezolizumab
  • San Francisco, California
  • +3 more
Apr 26, 2018

Locally Advanced and/or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma Trial

Completed
  • Locally Advanced and/or Metastatic Renal Cell Carcinoma
  • +2 more
  • Erlangen, Germany
  • +7 more
Aug 22, 2017

Clear-cell Metastatic Renal Cell Carcinoma, Bone Metastases Trial in France (XOFIGO)

Unknown status
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Bone Metastases
  • Bordeaux, France
  • +4 more
Nov 7, 2016

Clear-cell Renal Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in France (Everolimus)

Completed
  • Clear-cell Renal Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Besançon, France
  • +9 more
Aug 18, 2016